These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4425641)

  • 1. Penetration of trimethoprim and sulphamethoxazole into the aqueous humour.
    Pohjanpelto PE; Sarmela TJ; Raines T
    Br J Ophthalmol; 1974 Jun; 58(6):606-8. PubMed ID: 4425641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Penetration of sulfamethoxazole and trimethoprim into the anterior chamber in humans (author's transl)].
    Rieder J; Ellerhorst B; Schwartz DE
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1974 Mar; 190(1):51-61. PubMed ID: 4611258
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.
    Bach MC; Gold O; Finland M
    J Infect Dis; 1973 Nov; 128():Suppl:584-99 p. PubMed ID: 4758050
    [No Abstract]   [Full Text] [Related]  

  • 4. Data on the pharmacokinetics of sulphamethoxazole and trimethoprim in buffalo calves.
    Jain SK; Uppal RP
    Zentralbl Veterinarmed A; 1984 Feb; 31(1):25-30. PubMed ID: 6426202
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).
    Patel RB; Welling PG
    Clin Pharmacokinet; 1980; 5(5):405-23. PubMed ID: 7408366
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; McFaden K; Jack ML; Weissman L
    J Infect Dis; 1973 Nov; 128():Suppl:547-55 p. PubMed ID: 4758045
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of pharmacokinetic interaction between glibenclamide and trimethoprim-sulphamethoxazole.
    Sjöberg S; Wiholm BE; Gunnarsson R; Emilsson H; Thunberg E; Christenson I; Ostman J
    Diabet Med; 1987; 4(3):245-7. PubMed ID: 2956028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
    Wright WL; Larking P; Lovell-Smith CJ
    Br J Urol; 1982 Oct; 54(5):550-1. PubMed ID: 6983378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentration of trimethoprim and sulphamethoxazole in the urine and serum of incontinent patients undergoing long-term treatment.
    Brandberg A
    Scand J Infect Dis Suppl; 1976; (8):54-5. PubMed ID: 1064913
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability study of Sumetrolim syrup.
    Arr M
    Ther Hung; 1983; 31(2):75-9. PubMed ID: 6336276
    [No Abstract]   [Full Text] [Related]  

  • 11. A bioavailability study on three oral preparations of the combination trimethoprim-sulfamethoxazole.
    Langlois Y; Gagnon MA; Tétreault L
    J Clin Pharmacol New Drugs; 1972; 12(5):196-200. PubMed ID: 4555878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-trimoxazole: kinetic differences and the route of administration.
    Lazaro A; Badia A
    J Antimicrob Chemother; 1977 Sep; 3(5):528-9. PubMed ID: 903337
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.
    Welling PG; Craig WA; Amidon GL; Kunin CM
    J Infect Dis; 1973 Nov; 128():Suppl:556-66 p. PubMed ID: 4758046
    [No Abstract]   [Full Text] [Related]  

  • 15. The concentration of sulphamethoxazole and trimethoprim in human prostate gland.
    Oosterlinck W; Defoort R; Renders G
    Br J Urol; 1975 Jun; 47(3):301-4. PubMed ID: 1095105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic consequences of the mode of administration of cotrimoxazole in humans].
    Kremers P; Mélon G; Heusghem C
    Rev Med Liege; 1975 Feb; 30(4):103-9. PubMed ID: 1224089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-pharmacological studies on the pharmacokinetics of a combination sulfamethoxazol/trimethoprim in normal subjects (author's transl)].
    Donike M; Lücker PW; Simon B
    Arzneimittelforschung; 1977; 27(12):2373-7. PubMed ID: 580054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Technology and pharmacokinetics of sulfamethoxazole-trimethoprim suppositories].
    Huszárné AM; Kálmán J; Kerkay E; Küttel D
    Acta Pharm Hung; 1980 Nov; 50(6):263-9. PubMed ID: 6973912
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimation of trimethoprim and sulfamethoxazole levels in tears after systemic administration.
    Sharma GK; Kabra SG; Garg RP; Sharma PK; Nepalia LK
    Indian J Ophthalmol; 1983 Jul; 31(4):447-9. PubMed ID: 6677607
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and clinical experiences of sulfadiazine in low doses alone and in combination with trimethoprim.
    Seppänen J
    Ann Clin Res; 1980; (25):4-18. PubMed ID: 7377749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.